Biodesix (NASDAQ:BDSX) just reported results for the first quarter of 2024.
- Biodesix reported earnings per share of -14 cents. This was above the analyst estimate for EPS of -15 cents.
- The company reported revenue of $14.82 million.
- This was 4.72% better than the analyst estimate for revenue of $14.15 million.